Skip to main content

Table 1 Clinical characteristics of amyloidosis patients at presentation (N = 56)

From: Incidence and risk factors of venous thromboembolism (VTD) in patients with amyloidosis

Characteristics  
Male/Female 39/17
Age (years)  
Median 67
Range (21–83)
Serum M-Protein (g/L) 1 (N = 18)
Mean 0.5
Median 0.2
Range (0–4.0)
24-hour Urine Protein (g) 1 (N = 47)
Mean 3.2
Median 0.4
Range (0–26.9)
BMPC* (%) 2 (N = 53)
Mean 8
Median 5
Range (0–50)
B 2 Microglobulin (mg/dl) 1 (N = 47)
Mean 3.4
Median 2.7
Range (0.3–18.4)
Serum albumin (g/L) 1 (N = 53)
Mean 3.4
Median 3.6
Range (1.0–5.4)
Immunoglobulin type Heavy Chain (N = 12)
IgA (%) 2 (17)
IgG (%) 9 (75)
IgM (%) 1 (8)
Unknown 0
Light Chain (N = 25)
λ 18 (72)
κ 7 (28)
History of VTD Personal  
Yes (%) 1 (2)
No (%) 53 (94)
Unknown (%) 2 (4)
Family  
No (%) 52 (93)
Unknown (%) 4 (7)
  1. 1 CCF Laboratory reference range, normal values:
  2. Serum M-protein: 0 g/dl
  3. Urine Protein: 0–0.15 g/24°
  4. β2 Macroglobulin: 0.3–1.9 mg/dl
  5. Serum Albumin: 3.5–5.0 g/L
  6. 2 Bone Marrow Plasma Cells